Single-Nucleus Multi-Omics Reveals Hypoxia-Driven Angiogenic Programs and Their Epigenetic Control in Sinonasal

Chaelin You1, Jaewoo Park1, Jung Yeon Jang2

  • 1Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju, Republic of Korea.

Insights

This study reveals subtypes of sinonasal squamous cell carcinoma (SNSCC) linked to poor outcomes. Targeting the adrenomedullin/VEGFA axis offers a new therapeutic strategy for this rare cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Sinonasal squamous cell carcinoma (SNSCC) is rare, with undefined molecular drivers and tumor microenvironment (TME).
  • Understanding SNSCC's cellular composition and TME is crucial for developing effective treatments.

Purpose of the Study:

  • To comprehensively map the SNSCC ecosystem using integrated multi-omic analyses.
  • To identify molecular drivers and therapeutic targets within the SNSCC tumor microenvironment.

Main Methods:

  • Integrated bulk and single-nucleus multi-omic analyses (transcriptomics, epigenomics).
  • In vitro functional studies and histological analysis of patient tissues.

Main Results:

  • Identified five distinct malignant cell populations in SNSCC, including hypoxic (TC1) and proliferative (TC2) subtypes associated with adverse outcomes.
  • TC1 cells drive hypoxia-induced angiogenesis via ADM, MIF, and VEGFA secretion, promoting endothelial tip cell (EC1) differentiation.
  • Epigenetic alterations, including DNA hypomethylation and chromatin accessibility changes at AP-1 sites, underpin these interactions, dependent on AP-1 and HIF1A signaling.

Conclusions:

  • Elucidated the epigenetic landscape governing tumor-stromal interactions in SNSCC.
  • Established the ADM/VEGFA axis as a critical therapeutic target to inhibit epigenetically controlled angiogenesis in SNSCC.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K